Published in Curr Protoc Immunol on November 01, 2010
Monitoring NK cell activity in patients with hematological malignancies. Oncoimmunology (2013) 0.81
Vav1 dephosphorylation by the tyrosine phosphatase SHP-1 as a mechanism for inhibition of cellular cytotoxicity. Mol Cell Biol (2003) 2.15
Protocadherin FAT1 binds Ena/VASP proteins and is necessary for actin dynamics and cell polarization. EMBO J (2004) 1.73
Activating natural cytotoxicity receptors of natural killer cells in cancer and infection. Trends Immunol (2013) 1.70
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244). Blood (2005) 1.61
Serial killing of tumor cells by human natural killer cells--enhancement by therapeutic antibodies. PLoS One (2007) 1.61
Integration of activating and inhibitory receptor signaling by regulated phosphorylation of Vav1 in immune cells. Sci Signal (2011) 1.57
Expression analysis of the ligands for the Natural Killer cell receptors NKp30 and NKp44. PLoS One (2007) 1.26
Activation of natural killer cells by newcastle disease virus hemagglutinin-neuraminidase. J Virol (2009) 1.20
Activating NK cell receptor ligands are differentially expressed during progression to cervical cancer. Int J Cancer (2008) 1.12
Altered glycosylation of recombinant NKp30 hampers binding to heparan sulfate: a lesson for the use of recombinant immunoreceptors as an immunological tool. Glycobiology (2007) 1.12
Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin. PLoS Pathog (2011) 1.11
Inhibitory receptor signals suppress ligation-induced recruitment of NKG2D to GM1-rich membrane domains at the human NK cell immune synapse. J Immunol (2007) 1.05
Regulation of 2B4 (CD244)-mediated NK cell activation by ligand-induced receptor modulation. Eur J Immunol (2006) 1.01
Fine-tuning of immune responses by SLAM-related receptors. J Leukoc Biol (2005) 1.01
2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells. Int Immunol (2006) 1.00
Cutting edge: NTB-A activates NK cells via homophilic interaction. J Immunol (2004) 0.99
The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding. J Biol Chem (2012) 0.98
Natural killer cells: fighting viruses and much more. Nat Immunol (2011) 0.96
Regulation of NK cell activity by 2B4, NTB-A and CRACC. Front Biosci (2008) 0.96
Surface CD107a/LAMP-1 protects natural killer cells from degranulation-associated damage. Blood (2013) 0.96
Comprehensive analysis of NK cell function in whole blood samples. J Immunol Methods (2008) 0.94
CD48 stimulation by 2B4 (CD244)-expressing targets activates human NK cells. J Immunol (2006) 0.94
Identification of CLEC12B, an inhibitory receptor on myeloid cells. J Biol Chem (2007) 0.93
Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells. Eur J Immunol (2007) 0.92
Glycosylation affects ligand binding and function of the activating natural killer cell receptor 2B4 (CD244) protein. J Biol Chem (2011) 0.92
Regulation of NK cell function by human granulocyte arginase. J Immunol (2009) 0.92
Blockade of natural killer cell-mediated lysis by NCAM140 expressed on tumor cells. Int J Cancer (2007) 0.89
Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation. Eur J Immunol (2009) 0.89
The use of trimeric isoleucine-zipper fusion proteins to study surface-receptor-ligand interactions in natural killer cells. J Immunol Methods (2004) 0.87
2-D DIGE analyses of enriched secretory lysosomes reveal heterogeneous profiles of functionally relevant proteins in leukemic and activated human NK cells. Proteomics (2008) 0.87
A unique secreted adenovirus E3 protein binds to the leukocyte common antigen CD45 and modulates leukocyte functions. Proc Natl Acad Sci U S A (2013) 0.86
Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. J Immunol (2006) 0.86
2B4 engagement mediates rapid LFA-1 and actin-dependent NK cell adhesion to tumor cells as measured by single cell force spectroscopy. J Immunol (2011) 0.85
Exposure of NK cells to intravenous immunoglobulin induces IFN gamma release and degranulation but inhibits their cytotoxic activity. Clin Immunol (2009) 0.85
Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib. Int J Cancer (2012) 0.82
NAB2 and EGR-1 exert opposite roles in regulating TRAIL expression in human Natural Killer cells. Immunol Lett (2013) 0.81
Enhancement of anti-tumor activity in vitro and in vivo by CD150 and SAP. Mol Immunol (2007) 0.81
WF10 stimulates NK cell cytotoxicity by increasing LFA-1-mediated adhesion to tumor cells. J Biomed Biotechnol (2011) 0.81
NK cells--from basic research to cancer therapy. Eur J Immunol (2007) 0.78
Multiple receptors trigger human NK cell-mediated cytotoxicity against porcine chondrocytes. J Immunol (2012) 0.77
Comparison of phenotype of gammadelta T cells generated using various cultivation methods. Immunol Lett (2009) 0.77
NK cell cytotoxicity mediated by 2B4 and NTB-A is dependent on SAP acting downstream of receptor phosphorylation. Front Immunol (2013) 0.76
Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion. J Med Chem (2017) 0.75
NK cells--versatile tools for viral defense and cancer treatment. Eur J Immunol (2013) 0.75
Recruitment of activating NK-cell receptors 2B4 and NKG2D to membrane microdomains in mammalian cells is dependent on their transmembrane regions. Eur J Immunol (2015) 0.75